At a glance
- Originator Kyoto Pharmaceutical Industries
- Class Alkanes; Antihyperlipidaemics; Indoles; Small molecules
- Mechanism of Action Antioxidants; Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia